PEDIATRICS Vol. 115 No. 1 January 2005, pp. 178-181 (doi:10.1542/peds.2004-2137)
EXPERIENCE AND REASON |
Lactobacillus Sepsis Associated With Probiotic Therapy

* Departments of Pediatrics
Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Probiotic strains of lactobacilli are increasingly being used in clinical practice because of their many health benefits. Infections associated with probiotic strains of lactobacilli are extremely rare. We describe 2 patients who received probiotic lactobacilli and subsequently developed bacteremia and sepsis attributable to Lactobacillus species. Molecular DNA fingerprinting analysis showed that the Lactobacillus strain isolated from blood samples was indistinguishable from the probiotic strain ingested by the patients. This report indicates, for the first time, that invasive disease can be associated with probiotic lactobacilli. This report should not discourage the appropriate use of Lactobacillus or other probiotic agents but should serve as a reminder that these agents can cause invasive disease in certain populations.
Key Words: Lactobacillus probiotic bacteremia sepsis
Abbreviations: CVC, central venous catheter MIC, minimal inhibitory concentration
Accepted Sep 30, 2004.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
T. Anderson, A. Lord, N. Shotkoski, and C. O'Keefe The Use of Probiotics for the Prevention of Necrotizing Enterocolitis in the Premature Infant ICAN: Infant, Child, & Adolescent Nutrition, October 1, 2009; 1(5): 246 - 252. [Abstract] [PDF] |
||||
![]() |
K. MILLER and T. FRASER Q: What is the role of probiotics in the treatment of acute Clostridium difficile-associated diarrhea? Cleveland Clinic Journal of Medicine, July 1, 2009; 76(7): 391 - 392. [Full Text] [PDF] |
||||
![]() |
C. Rouge, H. Piloquet, M.-J. Butel, B. Berger, F. Rochat, L. Ferraris, C. Des Robert, A. Legrand, M.-F. de la Cochetiere, J.-M. N'Guyen, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1828 - 1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Imhoff and K. Karpa Is There a Future for Probiotics in Preventing Clostridium difficile-Associated Disease and Treatment of Recurrent Episodes? Nutr Clin Pract, February 1, 2009; 24(1): 15 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sheth and M. Floch Probiotics and Diverticular Disease Nutr Clin Pract, February 1, 2009; 24(1): 41 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Koretz Probiotics, Critical Illness, and Methodologic Bias Nutr Clin Pract, February 1, 2009; 24(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wallace Clinical Use of Probiotics in the Pediatric Population Nutr Clin Pract, February 1, 2009; 24(1): 50 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Ewaschuk, H. Diaz, L. Meddings, B. Diederichs, A. Dmytrash, J. Backer, M. Looijer-van Langen, and K. L. Madsen Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1025 - G1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lopez, N. Li, J. Kataria, M. Russell, and J. Neu Live and Ultraviolet-Inactivated Lactobacillus Rhamnosus GG Decrease Flagellin-Induced Interleukin-8 Production in Caco-2 Cells J. Nutr., November 1, 2008; 138(11): 2264 - 2268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Thompson and J. Duffy Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients Nutr Clin Pract, October 1, 2008; 23(5): 533 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Eichenwald and A. R. Stark Management and Outcomes of Very Low Birth Weight N. Engl. J. Med., April 17, 2008; 358(16): 1700 - 1711. [Full Text] [PDF] |
||||
![]() |
J. A Pawitan Consider microbial cause BMJ, September 1, 2007; 335(7617): 414 - 414. [Full Text] [PDF] |
||||
![]() |
V. Vankerckhoven, P. Moreillon, S. Piu, M. Giddey, G. Huys, M. Vancanneyt, H. Goossens, and J. M. Entenza Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis J. Med. Microbiol., August 1, 2007; 56(8): 1017 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Isakow, L. E. Morrow, and M. H. Kollef Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations Chest, July 1, 2007; 132(1): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Segarra-Newnham Probiotics for Clostridium difficile-Associated Diarrhea: Focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii Ann. Pharmacother., July 1, 2007; 41(7): 1212 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Saavedra Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Neu, M. Douglas-Escobar, and M. Lopez Microbes and the Developing Gastrointestinal Tract Nutr Clin Pract, April 1, 2007; 22(2): 174 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alberda, L. Gramlich, J. Meddings, C. Field, L. McCargar, D. Kutsogiannis, R. Fedorak, and K. Madsen Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial Am. J. Clinical Nutrition, March 1, 2007; 85(3): 816 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Bu, X. Wang, Y.-Q. Zhu, R. Y. Williams, W. Hsueh, X. Zheng, R. A. Rozenfeld, X.-L. Zuo, and X.-D. Tan Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity J. Immunol., December 15, 2006; 177(12): 8767 - 8776. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hammerman, A. Bin-Nun, and M. Kaplan Safety of probiotics: comparison of two popular strains BMJ, November 11, 2006; 333(7576): 1006 - 1008. [Full Text] [PDF] |
||||
![]() |
C. Daniel, S. Poiret, D. Goudercourt, V. Dennin, G. Leyer, and B. Pot Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model Appl. Envir. Microbiol., September 1, 2006; 72(9): 5799 - 5805. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Johnston, A. L. Supina, and S. Vohra Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. Can. Med. Assoc. J., August 15, 2006; 175(4): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vancanneyt, G. Huys, K. Lefebvre, V. Vankerckhoven, H. Goossens, and J. Swings Intraspecific Genotypic Characterization of Lactobacillus rhamnosus Strains Intended for Probiotic Use and Isolates of Human Origin Appl. Envir. Microbiol., August 1, 2006; 72(8): 5376 - 5383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Boyle, R. M Robins-Browne, and M. L. Tang Probiotic use in clinical practice: what are the risks? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1256 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Cabana, A. L. Shane, C. Chao, and M. Oliva-Hemker Probiotics in Primary Care Pediatrics Clinical Pediatrics, June 1, 2006; 45(5): 405 - 410. [Abstract] [PDF] |
||||
![]() |
P Marteau, M Lemann, P Seksik, D Laharie, J F Colombel, Y Bouhnik, G Cadiot, J C Soule, A Bourreille, E Metman, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial Gut, June 1, 2006; 55(6): 842 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jesse and J. Neu Necrotizing Enterocolitis: Relationship to Innate Immunity, Clinical Features, and Strategies for Prevention NeoReviews, March 1, 2006; 7(3): e143 - e150. [Full Text] [PDF] |
||||
![]() |
A. N. Kunz, M. P. Fairchok, and J. M. Noel Lactobacillus Sepsis Associated With Probiotic Therapy Pediatrics, August 1, 2005; 116(2): 517 - 517. [Full Text] [PDF] |
||||
![]() |
A. K. Shetty and C. R. Woods Lactobacillus Sepsis Associated With Probiotic Therapy: In Reply Pediatrics, August 1, 2005; 116(2): 517 - 518. [Full Text] [PDF] |
||||






















